Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT01989598 · COMPLETED
Trial details
- NCT number
- NCT01989598
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-30
- Primary completion
- 2019-08-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.